Ledger.Open graph →
SEC Form D · Amendment · filed March 24, 2015

Genoa Pharmaceuticals, Inc

Offering
$2.0M
Sold
$1.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Daniel D. Burgess · San Diego, CADirectorRichard G. Vincent · San Diego, CAExecMark W. Surber, Ph.D · San Diego, CAExec · DirectorMichael J. Kamdar · San Diego, CADirectorDavid Judelson · San Diego, CAExecRobert L. Fransen · MINNEAPOLIS, MNDirectorBilly G. Sitton · Houston, TXDirectorTripp J. Keber · DENVER, COExec · DirectorIsaac Dietrich · DENVER, CODirectorEan J. Seeb · DENVER, CODirectorDaniel C. Hunt · DENVER, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗